<DOC>
	<DOCNO>NCT00207090</DOCNO>
	<brief_summary>The purpose study test rifampin affect removal BMS-247550 ( ixabepilone ) body .</brief_summary>
	<brief_title>Effect Rifampin Pharmacokinetics Ixabepilone Patients With Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Up three prior chemotherapy regimens Measurable nonmeasurable disease Available treatment followup Neuropathy Uncontrolled cardiovascular disease Refusal participate genetic analysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>